Sequence and analysis of the genome of a baculovirus pathogenic forLymantria dispar J Kuzio, MN Pearson, SH Harwood, CJ Funk, JT Evans, JM Slavicek, ... Virology 253 (1), 17-34, 1999 | 419 | 1999 |
The sequence of theOrgyia pseudotsugatamultinucleocapsid nuclear polyhedrosis virus genome CH Ahrens, RLQ Russell, CJ Funk, JT Evans, SH Harwood, ... Virology 229 (2), 381-399, 1997 | 368 | 1997 |
Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents JR Baldridge, P McGowan, JT Evans, C Cluff, S Mossman, D Johnson, ... Expert opinion on biological therapy 4 (7), 1129-1138, 2004 | 349 | 2004 |
Enhancement of antigen-specific immunity via the TLR4 ligands MPL™ adjuvant and Ribi. 529 JT Evans, CW Cluff, DA Johnson, MJ Lacy, DH Persing, JR Baldridge Expert review of vaccines 2 (2), 219-229, 2003 | 347 | 2003 |
A scalable concurrent malloc (3) implementation for FreeBSD J Evans Proc. of the bsdcan conference, ottawa, canada, 2006 | 342 | 2006 |
Structure-activity relationship of synthetic toll-like receptor 4 agonists AG Stöver, JDS Correia, JT Evans, CW Cluff, MW Elliott, EW Jeffery, ... Journal of Biological Chemistry 279 (6), 4440-4449, 2004 | 194 | 2004 |
The low-toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells BS Thompson, PM Chilton, JR Ward, JT Evans, TC Mitchell Journal of leukocyte biology 78 (6), 1273-1280, 2005 | 175 | 2005 |
Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge CW Cluff, JR Baldridge, AG Stöver, JT Evans, DA Johnson, MJ Lacy, ... Infection and immunity 73 (5), 3044-3052, 2005 | 147 | 2005 |
Human cord blood CD34+ CD38-cell transduction via lentivirus-based gene transfer vectors JT Evans, PF Kelly, E O'Neill, JV Garcia Human gene therapy 10 (9), 1479-1489, 1999 | 100 | 1999 |
Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist WS Bowen, LA Minns, DA Johnson, TC Mitchell, MM Hutton, JT Evans Science signaling 5 (211), ra13-ra13, 2012 | 93 | 2012 |
Characterization of the interaction between the baculovirus replication factors LEF-1 and LEF-2 JT Evans, DJ Leisy, GF Rohrmann Journal of virology 71 (4), 3114-3119, 1997 | 93 | 1997 |
Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection A Maroof, YM Yorgensen, Y Li, JT Evans PLoS pathogens 10 (1), e1003875, 2014 | 89 | 2014 |
Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors J Douglas, P Kelly, JT Evans, JV Garcia Human gene therapy 10 (6), 935-945, 1999 | 89 | 1999 |
PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccination HS Oberoi, YM Yorgensen, A Morasse, JT Evans, DJ Burkhart Journal of Controlled Release 223, 64-74, 2016 | 72 | 2016 |
Immunoregulatory activity of the natural product laminarin varies widely as a result of its physical properties AJ Smith, B Graves, R Child, PJ Rice, Z Ma, DW Lowman, HE Ensley, ... The Journal of Immunology 200 (2), 788-799, 2018 | 71 | 2018 |
Lentivirus vector mobilization and spread by human immunodeficiency virus JT Evans, JV Garcia Human gene therapy 11 (17), 2331-2339, 2000 | 62 | 2000 |
The baculovirus single-stranded DNA binding protein, LEF-3, forms a homotrimer in solution JT Evans, GF Rohrmann Journal of virology 71 (5), 3574-3579, 1997 | 59 | 1997 |
Scalable memory allocation using jemalloc J Evans | 57 | 2011 |
Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529 JR Baldridge, CW Cluff, JT Evans, MJ Lacy, JR Stephens, VG Brookshire, ... Journal of endotoxin research 8 (6), 453-458, 2002 | 54 | 2002 |
Purification of native α-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic GC Whiting, JT Evans, S Patel, SH Gillespie Journal of medical microbiology 51 (10), 837-843, 2002 | 54 | 2002 |